profit from every €100 of sales.
€0€100
Arkema
€57.30-0.61% today
+9.0% since Dec 18, 25
1-year low €48.461-year high €65.45
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €69.58 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Arkema sold, what it kept, and what it did with the cash.
Sales went from €11.6 billion in 2022 to €9.07 billion in 2025, with €63.0 million of profit last year.
SalesProfit
Arkema handed back 91% of the cash it generated last year.
€272M
Free cash flow 2025€337M
Bought back its own shares€33M
Paid as dividends€272M
Cash vs. debt€2.2B vs. €4.6B
Arkema vs. similar companies
Arkema grows the slowest of these 5 and is the most expensive for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Arkema | 69.6× · Very expensive | ||
 Linde | 34.6× · Expensive | ||
 L'Air Liquide | 34.4× · Expensive | ||
 The Sherwin-Williams | 33.7× · Expensive | ||
 Ecolab | 41.4× · Expensive |
AI analysis
An AI analyst reads Arkema's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 11,550 | 9,514 | 9,544 | 9,068 | |
| 2,580 | 1,960 | 1,939 | 1,614 | |
| 1,442 | 811 | 741 | 420 | |
| 1,971 | 1,315 | 1,339 | 1,076 | |
| 965 | 418 | 354 | 63 | |
| 12.75 | 5.36 | 4.49 | 0.51 | |
| 22.3% | 20.6% | 20.3% | 17.8% | |
| 12.5% | 8.5% | 7.8% | 4.6% | |
| 8.4% | 4.4% | 3.7% | 0.7% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 13,511 | 14,517 | 15,209 | 14,245 |
| Cash | 1,592 | 2,045 | 2,013 | 2,188 |
| Total debt | 3,258 | 4,275 | 4,554 | 4,558 |
| Total liabilities | 6,172 | 7,062 | 7,448 | 7,213 |
| 7,300 | 7,203 | 7,526 | 6,843 | |
| 74 | 75 | 75 | 76 | |
| 9.0% | 4.1% | 3.3% | 1.6% | |
| 13.2% | 5.8% | 4.7% | 0.9% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,496 | 1,272 | 1,121 | 997 | |
| 730 | 679 | 761 | 660 | |
| 766 | 593 | 360 | 337 | |
| Dividends paid | 222 | 253 | 261 | 272 |
| 22 | 32 | 35 | 33 | |
| – | – | – | – |
Valuation
- 69.6×
- –
- –
- 0.7×
- 0.5×
- 13.0×
- 6.3×
- 7.7%
- 1.4%
- 6.2%
Profitability
- 17.8%
- 4.6%
- 0.7%
- –
- 1.6%
- 4.5%
- –
- –
- –
- –
Growth
- −7.7%
- −65.8%
- –
- –
- +0.7%
Financial health
- 2.2×
- 0.67
- –
- 3.1×
- 2.13
- –
- –
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 20%of 988
Bottom 24%of 948
Bottom 11%of 768
Bottom 16%of 927
Top 19%of 987
6.2%of the share price, paid each year
On $1,000 invested$62a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
431.7% of its profit
Room to growStretchedMore than it earns: 80.7%
News
Arkema S.A. reports Q3 resultsSeeking Alpha · Nov 5, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
31No pass
Benjamin Graham
61Pass
Philip Fisher
11No pass
Peter Lynch
15No pass
Joel Greenblatt
5No pass
Charlie Munger
15No pass
Terry Smith
17No pass
Questions about Arkema
Is Arkema a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Arkema AI analysis
What does Arkema do?
Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It is in Specialty Chemicals, based in Puteaux, France, with 20,700 employees.
Does Arkema pay a dividend?
Yes. At today's price the dividend is 6.2% a year. In 2025 it paid out €272 million in dividends.
Is Arkema stock halal?
No. Arkema does not pass our halal screen: its debt is 104% of its market value, at or above the 33% limit. How we check
Who are Arkema's competitors?
The largest listed companies in the same industry are Linde, L'Air Liquide, The Sherwin-Williams and Ecolab. The peers table on this page compares their profit, growth and price with Arkema's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.